Filing Details
- Accession Number:
- 0001562180-20-003453
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-07 16:34:44
- Reporting Period:
- 2020-05-05
- Accepted Time:
- 2020-05-07 16:34:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434418 | Constellation Pharmaceuticals Inc | CNST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1437152 | Karen Valentine | C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-05 | 4,744 | $11.50 | 4,744 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-05 | 4,744 | $40.01 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-05-06 | 10,099 | $11.50 | 10,099 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-05-06 | 2,467 | $8.76 | 12,566 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-06 | 12,566 | $40.10 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-05 | 4,744 | $0.00 | 4,744 | $11.50 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 10,099 | $0.00 | 10,099 | $11.50 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-05-06 | 2,467 | $0.00 | 2,467 | $8.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
109,241 | 2028-07-18 | No | 4 | M | Direct | |
99,142 | 2028-07-18 | No | 4 | M | Direct | |
22,425 | 2029-03-06 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $40.00 to $40.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $40.00 to $40.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022.
- This option was granted on March 7, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments through March 7, 2023.